{"title":"血液透析(HD)透析液钾","authors":"D. Tovbin, Karim Awad","doi":"10.33552/aun.2019.01.000506","DOIUrl":null,"url":null,"abstract":"Extremes of serum potassium levels in the general population, cardiac patients and hemodialysis (HD) patients may be critical. Thus, dialysate potassium concentration needs to be individualized to the patients by a standardized approach of the nephrologists. Our goals are to avoid or minimize pre-HD hyperkalemia, post-HD hypokalemia and high intradialytic dialysate-plasma K gradient, in order to moderate the high mortality and morbidity in HD patients and improve their compromised quality of life (QOL). However, dialysate K is frequently not individualized.","PeriodicalId":93263,"journal":{"name":"Annals of urology & nephrology","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Hemodialysis (HD) Dialysate Potassium\",\"authors\":\"D. Tovbin, Karim Awad\",\"doi\":\"10.33552/aun.2019.01.000506\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Extremes of serum potassium levels in the general population, cardiac patients and hemodialysis (HD) patients may be critical. Thus, dialysate potassium concentration needs to be individualized to the patients by a standardized approach of the nephrologists. Our goals are to avoid or minimize pre-HD hyperkalemia, post-HD hypokalemia and high intradialytic dialysate-plasma K gradient, in order to moderate the high mortality and morbidity in HD patients and improve their compromised quality of life (QOL). However, dialysate K is frequently not individualized.\",\"PeriodicalId\":93263,\"journal\":{\"name\":\"Annals of urology & nephrology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-01-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annals of urology & nephrology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33552/aun.2019.01.000506\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of urology & nephrology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33552/aun.2019.01.000506","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Extremes of serum potassium levels in the general population, cardiac patients and hemodialysis (HD) patients may be critical. Thus, dialysate potassium concentration needs to be individualized to the patients by a standardized approach of the nephrologists. Our goals are to avoid or minimize pre-HD hyperkalemia, post-HD hypokalemia and high intradialytic dialysate-plasma K gradient, in order to moderate the high mortality and morbidity in HD patients and improve their compromised quality of life (QOL). However, dialysate K is frequently not individualized.